agilon health (NYSE:AGL) Stock Price Down 5.8% – Here’s Why

by · The Cerbat Gem

agilon health, inc. (NYSE:AGL – Get Free Report) traded down 5.8% during trading on Monday . The company traded as low as $1.85 and last traded at $1.86. 572,119 shares changed hands during mid-day trading, a decline of 88% from the average session volume of 4,825,294 shares. The stock had previously closed at $1.97.

Analyst Upgrades and Downgrades

Several analysts have commented on AGL shares. Macquarie initiated coverage on shares of agilon health in a research note on Monday, December 16th. They set a “neutral” rating and a $3.00 price objective for the company. Sanford C. Bernstein initiated coverage on agilon health in a research note on Wednesday, December 11th. They set a “market perform” rating and a $2.50 price objective for the company. Royal Bank of Canada reissued an “outperform” rating and issued a $3.00 price target on shares of agilon health in a report on Tuesday, November 19th. William Blair lowered shares of agilon health from an “outperform” rating to a “market perform” rating in a report on Friday, November 8th. Finally, Evercore ISI lowered their price target on shares of agilon health from $7.00 to $4.00 and set an “in-line” rating on the stock in a report on Tuesday, October 8th. Three analysts have rated the stock with a sell rating, sixteen have given a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat, agilon health currently has a consensus rating of “Hold” and an average target price of $4.28.

Read Our Latest Stock Analysis on agilon health

agilon health Stock Performance

The company has a market cap of $786.95 million, a price-to-earnings ratio of -2.03 and a beta of 0.51. The stock’s fifty day simple moving average is $2.26 and its 200 day simple moving average is $4.15. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06.

agilon health (NYSE:AGL – Get Free Report) last announced its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). The company had revenue of $1.45 billion for the quarter, compared to analysts’ expectations of $1.47 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. During the same quarter in the previous year, the business posted ($0.06) EPS. As a group, analysts anticipate that agilon health, inc. will post -0.52 earnings per share for the current year.

Insider Activity

In other news, Director Diana Mckenzie purchased 12,500 shares of agilon health stock in a transaction dated Monday, November 25th. The shares were purchased at an average price of $2.28 per share, with a total value of $28,500.00. Following the transaction, the director now owns 51,319 shares in the company, valued at $117,007.32. This represents a 32.20 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Karen Mcloughlin acquired 25,000 shares of the stock in a transaction that occurred on Friday, December 13th. The stock was acquired at an average price of $2.20 per share, with a total value of $55,000.00. Following the completion of the transaction, the director now directly owns 73,166 shares of the company’s stock, valued at $160,965.20. This trade represents a 51.90 % increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders have bought 90,000 shares of company stock valued at $198,100. 3.20% of the stock is currently owned by insiders.

Institutional Trading of agilon health

Institutional investors and hedge funds have recently bought and sold shares of the stock. Bank of New York Mellon Corp raised its stake in shares of agilon health by 18.7% in the 2nd quarter. Bank of New York Mellon Corp now owns 1,108,921 shares of the company’s stock valued at $7,252,000 after acquiring an additional 174,883 shares during the period. Allspring Global Investments Holdings LLC lifted its position in shares of agilon health by 17,790.0% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 10,734 shares of the company’s stock worth $70,000 after purchasing an additional 10,674 shares during the last quarter. Principal Financial Group Inc. boosted its position in shares of agilon health by 42.4% during the 2nd quarter. Principal Financial Group Inc. now owns 41,675 shares of the company’s stock worth $273,000 after acquiring an additional 12,411 shares in the last quarter. Signaturefd LLC raised its holdings in agilon health by 166.2% during the second quarter. Signaturefd LLC now owns 11,848 shares of the company’s stock worth $77,000 after purchasing an additional 7,398 shares in the last quarter. Finally, nVerses Capital LLC acquired a new position in agilon health in the second quarter valued at $210,000.

About agilon health

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Recommended Stories